Diabetes, Pharma Companies & Digital

This great blog, “Lilly collaborating with digital firm in ‘real world’ diabetes studies” was written by Richard Staines and published on the Pharmaphorum website on Friday, January 12th, 2018…

“Pharma companies operating in diabetes are all investing in tech to help patients and doctors manage the condition – and will soon be competing not just on the strength of their medicines, but also on the digital services they can provide.

Eli Lilly is one of the diabetes companies that is active in this field, and signalled its intent to expand its digital offering by collaborating with health technology firm Livongo, to collaborate on real-world studies and develop new insights into diabetes.

Diabetes rivals like Novo Nordisk, Sanofi, and AstraZeneca are also competing to improve their digital offering.”

To finish reading the article, please go to the Pharmaphorum website.